Ceftazidime 250MG INJ About
Monark Biocare is the trusted ISO certified Pharma Company in Alwar. With a decade of experience, we have cemented our position as trusted manufacturers and suppliers of top-notch pharmaceutical products across India. We are WHO-GMP, GLP certified company in India with the exclusive range of pharma products. Our extensive product portfolio includes a diverse range of tablets, capsules, injectables, syrups, ointments, nasal drops, etc.
Broad-Spectrum Infection ControlCeftazidime 250MG Injection is part of the third-generation cephalosporin antibiotics, renowned for tackling a wide array of serious bacterial infections. This medicine is effective against both Gram-negative and certain Gram-positive bacteria, making it suitable for conditions like pneumonia, urinary tract infections, and intra-abdominal infections.
Flexible Administration RoutesDesigned for parenteral use, Ceftazidime can be administered through either intramuscular or intravenous injection. The powder must be reconstituted with sterile water for injection before use. This flexibility allows healthcare professionals to select the most appropriate route depending on patient condition and required onset of action.
Stringent Safety and Storage MeasuresCeftazidime is intended for use under prescription, prioritizing patient safety. It should not be mixed in the same syringe or infusion line with aminoglycosides. Store the vials in a cool, dry place, away from light, to ensure optimal efficacy. After reconstitution, the solution should be used promptly or refrigerated for up to 24 hours.
FAQ's of Ceftazidime 250MG INJ:
Q: How is Ceftazidime 250MG Injection supposed to be administered?
A: Ceftazidime 250MG Injection is given either intramuscularly or intravenously, as directed by a healthcare professional. The powder must be dissolved in sterile water for injection before administration.
Q: What types of infections does Ceftazidime 250MG Injection treat?
A: This antibiotic is used to treat a variety of moderate to severe infections, including pneumonia, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, septicemia, meningitis, and bone or joint infections.
Q: When should Ceftazidime 250MG be used after reconstitution?
A: The reconstituted solution should be used immediately. If storage is necessary, it may be refrigerated and used within 24 hours to ensure its effectiveness and safety.
Q: Where should Ceftazidime 250MG vials be stored before use?
A: Vials must be stored in a cool, dry place, protected from light. Once reconstituted, the solution should be refrigerated if not used immediately.
Q: What precautions should be taken during administration?
A: Ceftazidime should not be mixed with aminoglycosides in the same syringe or infusion line due to compatibility issues. Dosage and administration must strictly follow medical advice.
Q: Who should not use Ceftazidime 250MG Injection?
A: Individuals with known hypersensitivity to cephalosporin antibiotics should not use this product. Always inform your doctor of any allergies before starting treatment.
Q: What are the common side effects of Ceftazidime 250MG Injection?
A: Common side effects include nausea, diarrhea, skin rashes, allergic reactions, and irritation at the injection site. Severe reactions are rare but warrant immediate medical attention.